BridgeBio Oncology Therapeutics, Inc. (BBOT)
Market Closed
30 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
8. 50
+0.27
+3.218%
$
700.94M Market Cap
- P/E Ratio
- Div Yield
292,214 Volume
- Eps
$ 8.23
Previous Close 
Want to track BBOT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
BridgeBio Oncology Therapeutics, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Anthony Scaramucci SkyBridge Capital II LLC | 1.33M | $15.07M | $11.94M | -$3.13M | -20.77% |
 David Kim Paradigm Biocapital Advisors LP | 868,213 | $10.43M | $7.19M | -$3.24M | -31.05% |
 Taro Kuriyama Axq Capita LLP | 17,347 | $155,256 | $145,281.12 | -$9,974.88 | -6.42% |
 Hui Fai Tam Caitong International Asset Management Co. Ltd. | 4 | $36 | $33.68 | -$2.32 | -6.44% |
| WJ William Jones TEMA ETFs LLC | 93,339 | $820,531.52 | $835,384.05 | $14,852.53 | 1.81% |
